- Home
- BCML vs NMRA Comparison
BCML vs NMRA Comparison
Compare BCML & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- NMRA
- Stock Information
- Founded
- BCML 2004
- NMRA 2019
- Country
- BCML United States
- NMRA United States
- Employees
- BCML N/A
- NMRA N/A
- Industry
- BCML Major Banks
- NMRA
- Sector
- BCML Finance
- NMRA
- Exchange
- BCML Nasdaq
- NMRA Nasdaq
- Market Cap
- BCML 294.2M
- NMRA 121.0M
- IPO Year
- BCML N/A
- NMRA 2023
- Fundamental
- Price
- BCML $28.89
- NMRA $0.84
- Analyst Decision
- BCML
- NMRA Buy
- Analyst Count
- BCML 0
- NMRA 8
- Target Price
- BCML N/A
- NMRA $9.29
- AVG Volume (30 Days)
- BCML 31.9K
- NMRA 1.4M
- Earning Date
- BCML 07-17-2025
- NMRA 08-05-2025
- Dividend Yield
- BCML 2.77%
- NMRA N/A
- EPS Growth
- BCML N/A
- NMRA N/A
- EPS
- BCML 2.10
- NMRA N/A
- Revenue
- BCML $95,714,000.00
- NMRA N/A
- Revenue This Year
- BCML $1.20
- NMRA N/A
- Revenue Next Year
- BCML $6.66
- NMRA N/A
- P/E Ratio
- BCML $13.76
- NMRA N/A
- Revenue Growth
- BCML N/A
- NMRA N/A
- 52 Week Low
- BCML $19.26
- NMRA $0.61
- 52 Week High
- BCML $30.13
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- BCML 66.53
- NMRA 52.19
- Support Level
- BCML $27.40
- NMRA $0.72
- Resistance Level
- BCML $29.15
- NMRA $0.85
- Average True Range (ATR)
- BCML 0.77
- NMRA 0.07
- MACD
- BCML 0.19
- NMRA -0.01
- Stochastic Oscillator
- BCML 86.65
- NMRA 62.35
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.